This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sevita, BrightSpring sign quality-focused settlement with US FTC

By Ilana Kowarski ( January 30, 2026, 22:05 GMT | Comment) -- Private-equity-backed healthcare firm Sevita and its publicly traded acquisition target, BrightSpring Health Services, ratified a merger antitrust consent decree Friday with the US Federal Trade Commission to move forward with their $835 million deal. The FTC’s complaint against the companies, which offer round-the-clock, home-based treatment for intellectual and developmental disabilities, focused on potential harm to quality of care and the risk of a merger diminishing patients’ freedom of choice.Private-equity-backed healthcare firm Sevita and its publicly traded acquisition target, BrightSpring Health Services, ratified a merger antitrust consent decree Friday with the US Federal Trade Commission to move forward with their $835 million deal....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login